Evidence map›Paper›PMID 37502762›Full record

ArticleJournal of neuroendovascular therapy2021

COVID-19 Countermeasures in Acute Stroke.

Yoshifumi Tsuboi, Michihisa Narikiyo, Alisonkenji Kojima, Keita Hashimoto, So Ohashi, Hirokazu Nagasaki, Minami Wade, Chisaku Kambayashi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of neuroendovascular therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yoshifumi TsuboiNeurovascular Center, Department of Neurosurgery, Kawasakisaiwai Hospital, Kawasaki, Kanagawa, Japan.
Michihisa NarikiyoNeurovascular Center, Department of Neurosurgery, Kawasakisaiwai Hospital, Kawasaki, Kanagawa, Japan.
Alisonkenji KojimaNeurovascular Center, Department of Neurosurgery, Kawasakisaiwai Hospital, Kawasaki, Kanagawa, Japan.
Keita HashimotoNeurovascular Center, Department of Neurosurgery, Kawasakisaiwai Hospital, Kawasaki, Kanagawa, Japan.
So OhashiNeurovascular Center, Department of Neurosurgery, Kawasakisaiwai Hospital, Kawasaki, Kanagawa, Japan.
Hirokazu NagasakiNeurovascular Center, Department of Neurosurgery, Kawasakisaiwai Hospital, Kawasaki, Kanagawa, Japan.
Minami WadeNeurovascular Center, Department of Neurosurgery, Kawasakisaiwai Hospital, Kawasaki, Kanagawa, Japan.
Chisaku KambayashiNeurovascular Center, Department of Neurosurgery, Kawasakisaiwai Hospital, Kawasaki, Kanagawa, Japan.
Kawasaki Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The impact of coronavirus disease 2019 (COVID-19) is continuing, and the most important issue facing medical staff is how to provide medical care while preventing nosocomial infections. Since acute stroke treatment, particularly mechanical thrombectomy, is urgent, infection protection measures may not always be followed, which increases the risk of infection exposure. The measures and methods for patient screening, transport, zoning, and use of personal protective equipment (PPE) employed to prevent nosocomial infections of COVID-19 at our facility are described herein.

Indexed as

Cord Yellowcoronavirus disease 2019mechanical thrombectomy

Identifiers

PMID37502762
PMCPMC10370588
OpenAlexW3194010786

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.